Orbion develops and manufactures generic products in Oral solid category (Non-Penicillin and Non- Cephalosporins) for the USA and EU regions.
Approved by USFDA and EU regulatory agencies, OrBion has about 29 ANDAs and 29 DMFs approved as of date.
With state-of-the-art facilities, OrBion has integrated capabilities for development, manufacturing, packing and testing solid oral dosage products in various therapeutic forms.
OrBion suppliesfinished dose formulation to USA, UK and EU countries .
